J. Mogro

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer

T. Ng, C. Thng, A. Jeyasekharan, 2016, Oncotarget.